Vanda Pharmaceuticals  logo
Vanda Pharmaceuticals VNDA
€ 5.96 -1.86%

Geschäftsbericht 2025
hinzugefügt 12.02.2026

report update icon

Vanda Pharmaceuticals DSO 2011-2026 | VNDA

DSO Jährlich Vanda Pharmaceuticals

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
85.9 74.6 64.1 47.3 42.5 41.5 42.4 54.4 38.9 50.7 54.2 26.6 23.3 16.1 18.9

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
85.9 16.1 45.4

DSO Vierteljährlich Vanda Pharmaceuticals

2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
77.7 83.6 - 81 - - - 73.9 57.6 42.4 - 20.5 21.6 47.7 - 51.1 46.1 44.8 40.5 45.5 44.1 44.4 39.5 40.5 40.7 52.7 49.5 53.5 55.5 48.5 36.3 38.9 38.2 46.2 48.4 48.1 51.3 50.2 46.8 52.6 54 41.2 21.7 22.6 30.7 28.4 21.1 21.3 22.3 18.1 13.5 12.9 12.7 15.6 17.6 18.5 19.9 -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
83.6 12.7 40.2

DSO anderer Aktien in der Pharmaeinzelhändler

Name DSO Preis % 24h Marktkapitalisierung Land
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
50 $ 4.5 0.45 % $ 862 M canadaCanada
Agenus Agenus
AGEN
3.58 $ 3.64 9.31 % $ 108 M usaUSA
Agios Pharmaceuticals Agios Pharmaceuticals
AGIO
47.4 $ 35.08 -0.36 % $ 2.03 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
62.9 $ 1.39 0.36 % $ 357 M usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
58.1 $ 331.14 3.85 % $ 43.4 B usaUSA
Altimmune Altimmune
ALT
7.85 K $ 3.4 1.8 % $ 300 M usaUSA
Amgen Amgen
AMGN
81.2 $ 344.03 -1.12 % $ 185 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
55.7 $ 12.27 -1.68 % $ 3.85 B usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
77.3 $ 14.99 1.28 % $ 220 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
48.3 - -24.86 % $ 820 K usaUSA
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
114 $ 73.8 -0.55 % $ 1.43 B usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
222 - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
20.6 $ 0.88 -5.16 % $ 4.8 M chinaChina
Aquestive Therapeutics Aquestive Therapeutics
AQST
103 $ 4.12 -0.24 % $ 441 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
21.2 $ 8.14 1.31 % $ 223 M israelIsrael
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
Ardelyx Ardelyx
ARDX
58 $ 5.99 0.84 % $ 1.44 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.114 - - $ 26.5 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
106 $ 24.06 1.82 % $ 3.06 B usaUSA
Arvinas Arvinas
ARVN
4.66 $ 10.87 0.14 % $ 771 M usaUSA
Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals
ARWR
8.75 $ 60.28 -1.23 % $ 8.06 B usaUSA
Assembly Biosciences Assembly Biosciences
ASMB
25.1 $ 29.51 1.72 % $ 331 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
154 - - $ 2.17 B usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
16.2 K $ 3.62 1.82 % $ 8.71 B australiaAustralia